Expertise in
1
conditions

Dr. Meenakshi Budhraja

Gastroenterology
New York City Health And Hospital Corporation
1901 1st Ave, 
New York, NY 
Expertise in
1
conditions
New York City Health And Hospital Corporation
1901 1st Ave, 
New York, NY 

Overview

Meenakshi Budhraja is a Gastroenterologist practicing medicine in New York, New York.

Dr. Budhraja is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Viral Gastroenteritis, Colitis, and Gastrointestinal Bleeding.

She is actively involved in clinical research, participating in 5 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in AR

Hospital Affiliations

Metropolitan Hospital Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HMO Partners
  • POS
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
QualChoice
  • MEDICARE MAPD
  • OTHER COMMERCIAL

Locations

New York City Health and Hospital Corporation
1901 1st Ave, New York, NY 10029
Other Locations
Conway Regional Medical Center Inc
2302 College Ave, Conway, AR 72034

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Enrollment Status: Terminated
Publish Date: April 29, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
18
conditions
Dr. David Katzka
Gastroenterology
Expertise in
18
conditions
Dr. David Katzka
Gastroenterology
Referral may be required

ColumbiaDoctors - Midtown

51 W 51st St Ste 360, 
New York, NY 
 (4.2 miles away)
646-661-2756
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Katzka is a Gastroenterologist practicing medicine in New York, New York. Dr. Katzka is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Esophagitis, Eosinophilic Esophagitis, Barrett Esophagus, Endoscopy, and Gastrectomy.

Expertise in
31
conditions
Dr. Thomas Schiano
Gastroenterology
Expertise in
31
conditions
Dr. Thomas Schiano
Gastroenterology
Referral may be required

Recanati Miller Transplantation Institute

5 E 98th St Fl 12, 
New York, NY 
 (1.6 miles away)
212-257-0031
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Thomas Schiano is a Gastroenterologist practicing medicine in New York, New York. Dr. Schiano is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Autoimmune Hepatitis, Liver Transplant, and Splenectomy.

Expertise in
23
conditions
Dr. Douglas Dieterich
Gastroenterology
Expertise in
23
conditions
Dr. Douglas Dieterich
Gastroenterology
Referral may be required

MSSM-Optical Shop

17 E 102nd St, 
New York, NY 
 (1.7 miles away)
212-241-7270
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Douglas Dieterich is a Gastroenterologist practicing medicine in New York, New York. Dr. Dieterich is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Cirrhosis, Non-Alcoholic Fatty Liver Disease, and Liver Transplant.

Frequently Asked Questions about Dr. Meenakshi Budhraja

How do I make an appointment with Dr. Meenakshi Budhraja?

You can book an appointment with Dr. Meenakshi Budhraja by calling their office at 212-423-6262. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Meenakshi Budhraja a top-rated expert for Gastroesophageal Reflux Disease (GERD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Meenakshi Budhraja is classified as an Advanced expert for Gastroesophageal Reflux Disease (GERD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Meenakshi Budhraja specialize in?

While Dr. Meenakshi Budhraja is a Gastroenterology, they have specific expertise in Gastroesophageal Reflux Disease (GERD), Viral Gastroenteritis, and Colitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Meenakshi Budhraja accept my insurance?

Dr. Meenakshi Budhraja accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 212-423-6262 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Budhraja's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile